Tower Research Capital LLC (TRC) - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q4 2022$9
-100.0%
10,398
-35.9%
0.00%
Q3 2022$21,000
+40.0%
16,210
-3.7%
0.00%
Q2 2022$15,000
+275.0%
16,825
+1255.8%
0.00%
Q1 2022$4,0001,2410.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders